This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.
USC’s Phase II clinical trial proves ProLon FMD is the first food technology that treats ageing and reduces risk factors for multiple age-related diseases
A new study finds that providing the body with a temporary, specifically formulated Fasting Mimicking Diet (FMD™) called ProLon® causes cellular changes normally generated by several days of consecutive water-only